Synergistic Actions of Glucagon and Miniglucagon on Ca2+ Mobilization in Cardiac Cells

Circulation Research

Volumn 78, Issue 1, 1996, Pages 102-109

  Sauvadet, Anne ^a   Rohn, Troy ^a   Pecker, Françoise ^a   Pavoine, Catherine ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Ca2+; Cardiac cells; Glucagon; Miniglucagon

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM MAGNESIUM); CALCIUM ION; CYCLIC AMP; GLUCAGON; GLUCAGON DERIVATIVE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CHICK EMBRYO; DRUG POTENTIATION; EMBRYO; ENZYME ACTIVATION; HEART MUSCLE CELL; HORMONAL REGULATION; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELLS, CULTURED; CHICK EMBRYO; DRUG SYNERGISM; GLUCAGON; HEART VENTRICLES; ISRADIPINE; PEPTIDE FRAGMENTS; SARCOPLASMIC RETICULUM;

EID: 0030021233     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.1.102     Document Type: Article

References (34)

1. Farah A, Tuttle R. Studies of the pharmacology of glucagon. J Pharmacol Exp Ther. 1960;129:49-55.
2. Robson RH. Glucagon for beta-blocker poisoning. Lancet. 1980;1: 1357-1358.
3. Parmley WW. The role of glucagon in cardiac therapy. N Engl J Med. 1971;285:801-802.
4. Zaritsky AL, Horowitz M, Chernow B. Glucagon antagonism of calcium channel blocker-induced myocardial dysfunction. Crit Care Med. 1988;16:246-251.
5. Sener EK, Gabe S, Henry JA. Response to glucagon in imipramine overdose. Clin Taxicol. 1995;33:51-53.
6. Pavoine C, Brechler V, Kervran A, Blache P, Le-Nguyen D, Laurent S, Bataille D, Pecker F. Miniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagon. Am J Physiol. 1991;260:C993-C999.
7. 2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidase. J Biol Chem. 1990;265:21514-21519.
8. Blache P, Kervran A, Le-Nguyen D, Dufour M. Cohen-Solal A, Duckworth W, Bataille D. Endopeptidase from rat liver membranes, which generates miniglucagon from glucagon. J Biol Chem. 1993;268:21748-21753.
9. 2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase. Nature. 1990; 345:158-161.
10. 2+ current and adenylate cyclase in cardiac cells. In: Korecky B, Dhalla NS, eds. Subcellular Basis of Contractile Failure. Norwell, Mass: Kluwer Academic Publishers; 1990:39-54.
11. Brechler V, Pavoine C, Hanf R, Garbarz E, Fischmeister R, Pecker F. Inhibition by glucagon of the cGMP-inhibited low-Km cyclic AMP phosphodiesterase in heart is mediated by a pertussis toxin-sensitive G-protein. J Biol Chem. 1992;267:15496-15501.
12. 2+ pump by glucagon. Nature. 1987;325:620-622.
13. 2+ pump which is mediated by G proteins. J Biol Chem. 1990;265:9876-9880.
14. s mediates hormonal inhibition of the calcium pump in liver plasma membranes. J Biol Chem. 1993;268:2368-2372.
15. 2+ contents, monovalent cation transport rate, and contractile state during washout of cardiac glycosides from cultured chick heart cells. Circ Res. 1981;49:141-149.
16. Marsh JD, Dionne MAM, Chiu M, Smith TW. A dihydropyridine calcium channel blocker with phosphodiesterase inhibitory activity: effects on cultured vascular smooth muscle and cultured heart cells. J Mol Cell Cardiol. 1988;20:1141-1150.
17. Altschuld RA, Wenger WC, Lamka KG, Kindig OR, Capen CC, Mizuhira V, Vander Heide RS, Brierley GP. Structural and functional properties of adult rat heart myocytes lysed with digitonin. J Biol Chem. 1985;260:14325-14334.
18. Donnadieu E, Bismuth G, Trautmann A. Calcium fluxes in T lymphocytes. J Biol Chem. 1992;267:25864-25872.
19. Donnadieu E, Cefai D, Tan YP, Paresys G, Bismuth G, Trautmann A. Imaging early steps of human T cell activation by antigen-presenting cells. J Immunol. 1992;148:2643-2653.
20. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
21. Pucéat M, Clément O, Scamps F, Vassort G. Extracellular ATP-induced acidification leads to cytosolic calcium transient rise in single rat cardiac myocytes. Biochem J. 1991;274:55-62.
22. i during caffeine contractures in rabbit cardiac myocytes. J Physiol (Lond). 1992;453: 591-608.
23. 2+ release during diastole and systole in isolated rat ventricular myocytes. J Physiol (Lond). 1990;430:519-536.
24. Godfraind T. Cardioselectivity of calcium antagonists. Cardiovasc Drugs Ther. 1994;8:353-364.
25. 2+ depletes sarcoplasmic reticulum in intact cardiac myocytes. Am J Physiol. 1993;265:H517-H522.
26. Näbauer M, Callewaert G, Cleeman L, Morad M. Regulation of calcium release is gated by calcium current, not gating charge, in cardiac myocytes. Science. 1989;244:800-803.
27. 2+ pump activity during diabetes mellitus. Am J Physiol. 1987;252:540-544.
28. 2+-pumping ATPase of heart sarcolemma from cardiomyopathic hamster. Biochim Biophys Acta. 1987;900:10-16.
29. 2+ transport. Mol Cell Biochem. 1992;112:125-133.
30. Takasago T, Imagawa T, Shigekawa M. Phosphorylation of the cardiac ryanodine receptor by cyclic AMP-dependent protein kinase. J Biochem. 1989;106:872-877.
31. Cheng H, Lederer WJ, Cannell MB. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science. 1993;262:740-744.
32. 2-adrenergic receptor. Science. 1994;264:582-586.
33. 2+ dynamics, contractility, or phospholamban phosphorylation. J Biol Chem. 1994;269:19151-19156.
34. Buxton ILO, Brunton LL. Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes. J Biol Chem. 1983; 258:10233-10239.